| Product Code: ETC13333502 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Nuclear Medicines Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Nuclear Medicines Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Nuclear Medicines Market Revenues & Volume, 2021 & 2031F |
3.3 North America Nuclear Medicines Market - Industry Life Cycle |
3.4 North America Nuclear Medicines Market - Porter's Five Forces |
3.5 North America Nuclear Medicines Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Nuclear Medicines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 North America Nuclear Medicines Market Revenues & Volume Share, By Application Area, 2021 & 2031F |
3.8 North America Nuclear Medicines Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 North America Nuclear Medicines Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
4 North America Nuclear Medicines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Nuclear Medicines Market Trends |
6 North America Nuclear Medicines Market, 2021 - 2031 |
6.1 North America Nuclear Medicines Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Nuclear Medicines Market, Revenues & Volume, By Diagnostic Radiopharmaceuticals, 2021 - 2031 |
6.1.3 North America Nuclear Medicines Market, Revenues & Volume, By Therapeutic Radiopharmaceuticals, 2021 - 2031 |
6.2 North America Nuclear Medicines Market, Revenues & Volume, By Application Area, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Nuclear Medicines Market, Revenues & Volume, By Oncology Imaging, 2021 - 2031 |
6.2.3 North America Nuclear Medicines Market, Revenues & Volume, By Thyroid Treatment, 2021 - 2031 |
6.2.4 North America Nuclear Medicines Market, Revenues & Volume, By Cardiac Imaging, 2021 - 2031 |
6.2.5 North America Nuclear Medicines Market, Revenues & Volume, By Bone Pain Palliation, 2021 - 2031 |
6.3 North America Nuclear Medicines Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Nuclear Medicines Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.3 North America Nuclear Medicines Market, Revenues & Volume, By Endocrinology Clinics, 2021 - 2031 |
6.3.4 North America Nuclear Medicines Market, Revenues & Volume, By Cardiology Centers, 2021 - 2031 |
6.3.5 North America Nuclear Medicines Market, Revenues & Volume, By Cancer Treatment Centers, 2021 - 2031 |
6.4 North America Nuclear Medicines Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.4.2 North America Nuclear Medicines Market, Revenues & Volume, By Technetium-99m, 2021 - 2031 |
6.4.3 North America Nuclear Medicines Market, Revenues & Volume, By Iodine-131, 2021 - 2031 |
6.4.4 North America Nuclear Medicines Market, Revenues & Volume, By Thallium-201, 2020 - 2028 |
6.4.5 North America Nuclear Medicines Market, Revenues & Volume, By Samarium-153, 2020 - 2028 |
7 North America Nuclear Medicines Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Nuclear Medicines Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.1 United States (US) Nuclear Medicines Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.2 Canada Nuclear Medicines Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.3 Rest of North America Nuclear Medicines Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3 North America Nuclear Medicines Market Revenues & Volume Share, By Application Area, 2021 & 2031F |
7.3.1 United States (US) Nuclear Medicines Market, Revenues & Volume, By Application Area, 2021 - 2031 |
7.3.2 Canada Nuclear Medicines Market, Revenues & Volume, By Application Area, 2021 - 2031 |
7.3.3 Rest of North America Nuclear Medicines Market, Revenues & Volume, By Application Area, 2021 - 2031 |
7.4 North America Nuclear Medicines Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.1 United States (US) Nuclear Medicines Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.2 Canada Nuclear Medicines Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.3 Rest of North America Nuclear Medicines Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5 North America Nuclear Medicines Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.5.1 United States (US) Nuclear Medicines Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.5.2 Canada Nuclear Medicines Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.5.3 Rest of North America Nuclear Medicines Market, Revenues & Volume, By Product Type, 2021 - 2031 |
8 North America Nuclear Medicines Market Key Performance Indicators |
9 North America Nuclear Medicines Market - Export/Import By Countries Assessment |
10 North America Nuclear Medicines Market - Opportunity Assessment |
10.1 North America Nuclear Medicines Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Nuclear Medicines Market Opportunity Assessment, By Type, 2021 & 2031F |
10.3 North America Nuclear Medicines Market Opportunity Assessment, By Application Area, 2021 & 2031F |
10.4 North America Nuclear Medicines Market Opportunity Assessment, By End User, 2021 & 2031F |
10.5 North America Nuclear Medicines Market Opportunity Assessment, By Product Type, 2021 & 2031F |
11 North America Nuclear Medicines Market - Competitive Landscape |
11.1 North America Nuclear Medicines Market Revenue Share, By Companies, 2022 |
11.2 North America Nuclear Medicines Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here